stockrowAquestive Therapeutics, Inc. (AQST) vs Collegium Pharmaceutical, Inc. (COLL)
- Aquestive Therapeutics, Inc. AQST 3.57 −2.46%
- Collegium Pharmaceutical, Inc. COLL 24.58 −2.31%
Aquestive Therapeutics, Inc. and Collegium Pharmaceutical, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $819.1M against $460.0M — 1.8× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 20.5×. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 12.5% against 7.68%. Collegium Pharmaceutical, Inc. has the higher net margin (4.68% vs −162.3%) and the higher return on invested capital (5.63% vs 0.00%). Across the 18 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AQST | COLL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 59.05% | 53.51% |
| Operating margin | (114.12%) | 15.22% | 0.00% |
| Net margin | (162.33%) | 4.68% | (2.45%) |
| Free cash flow margin | (83.33%) | 41.25% | 0.00% |
| Return on equity | 211.59% | 13.36% | (0.80%) |
| Return on assets | (56.05%) | 2.06% | (1.67%) |
| Return on invested capital | 0.00% | 5.63% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack